Cochlear Osake

Cochlear EV/FCF

EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) yhtiöstä Cochlear (COH.AX) 22.6.2026 päivämäärällä on 83,23.Edellisenä vuonna EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) oli 36,81 — muutos 126,11 % (korkeampi).

EV/FCF

83,23

YoY

126,11%

Viimeksi päivitetty:

EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) yhtiöstä Cochlear on 2026 83,23 . EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) yhtiöstä Cochlear oli 2025 36,81 . Se laskee 126,11% korkeampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Cochlear Osakeanalyysi

Mitä Cochlear tekee? Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Cochlear osakkeesta

EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) oli Cochlear 36,81 83,23

Access this data via the Eulerpool API

Arvostus — Cochlear

Kaikki tunnusluvut — Cochlear